The goals of the New Directions in Biology and Disease of Skeletal Muscle conference are to: (1) provide a unique forum for presentation and sharing of unpublished data, (2) promote collaboration between industry and academic investigators, (3) provide an interactive forum for clinical trial planning and outcome measure development, (4) facilitate the identification of both common and unique targets for each neuromuscular disease, and (5) provide trainees and young investigators a forum in which to present data and to encourage trainees to remain studying neuromuscular disease.
Contact:
Dr. John D. Porter,
301-496-5739,
Co-funding Institute(s):
National Institute of Neurological Disorders and Stroke
Office of Rare Diseases Research